Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis

Published:2020-01-23 Issue:11 Volume:105 Page:2659-2663
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Jan Philipp Bewersdorf ,Smith Giri ,Rong Wang ,Robert T. Williams ,Martin S. Tallman ,Amer M. Zeidan ,Maximilian Stahl

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD22 Calecheamicin-Inotuzumab Ozogamicin Combined with Venetoclax + Azatabine in the Treatment of Mixed Phenotype Acute Leukemia: A Case Report;Turkish Journal of Hematology;2024-07-30

2. Novel insights and therapeutic approaches in secondary AML;Frontiers in Oncology;2024-07-29

3. Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review;Oncology Letters;2024-06-25

4. The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study;Hematology;2024-05-15

5. Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies;Drug Resistance Updates;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP